Biotech Acquisition Co

Biotech Acquisition Co (Nasdaq: BIOT) was a blank-check company targeting the biotechnology and life sciences sector. On February 14, 2023, the company filed a Form 15-12G with the SEC, initiating the voluntary termination of its Exchange Act Section 12(g) registration — a filing that typically marks the close of a SPAC's public lifecycle following either a completed business combination or a dissolution. The sponsor behind BIOT has not been identified in publicly available filings. For the full filing history, sponsor details, and deal timeline on Biotech Acquisition Co, sign up for complete data access at SpacDesk.